The bill seeks to improve health insurance coverage for individuals diagnosed with advanced or metastatic cancer by prohibiting insurers from requiring patients to show a lack of response to alternative medications before covering FDA-approved drugs that align with national comprehensive cancer network guidelines. It also introduces the term "terminal cancer," defining it as cancer that is incurable and expected to result in death. Additionally, the bill amends existing sections of the Montana Code Annotated (MCA) to ensure that health insurance contracts include coverage for treatments related to advanced or metastatic cancer, while also mandating coverage for other health services such as well-child care and mental health services.
Furthermore, the bill makes specific amendments to Sections 2-18-704, 33-31-111, and 33-35-306 of the MCA, which detail the application of the insurance code to self-funded multiple employer welfare arrangements. It clarifies that these arrangements are subject to various provisions of Title 33, while also stating that other provisions do not apply if they hold a valid certificate of authority. Overall, the bill aims to enhance protections for individuals with advanced or metastatic cancer by ensuring they have access to necessary treatments without facing undue restrictions from insurance providers.
Statutes affected: LC Text: 2-18-704, 33-31-111, 33-35-306
SB0422_1(1): 2-18-704, 33-31-111, 33-35-306
SB0422_1(2): 2-18-704, 33-31-111, 33-35-306
SB0422_1(3): 2-18-704, 33-31-111, 33-35-306
SB0422_1(4): 2-18-704, 33-31-111, 33-35-306
SB0422_1: 2-18-704, 33-31-111, 33-35-306
SB0422_2(1): 2-18-704, 33-31-111, 33-35-306
SB0422_2(10): 2-18-704, 33-31-111, 33-35-306
SB0422_2(11): 2-18-704, 33-31-111, 33-35-306
SB0422_2(12): 2-18-704, 33-31-111, 33-35-306
SB0422_2(13): 2-18-704, 33-31-111, 33-35-306
SB0422_2(2): 2-18-704, 33-31-111, 33-35-306
SB0422_2(3): 2-18-704, 33-31-111, 33-35-306
SB0422_2(4): 2-18-704, 33-31-111, 33-35-306
SB0422_2(5): 2-18-704, 33-31-111, 33-35-306
SB0422_2(6): 2-18-704, 33-31-111, 33-35-306
SB0422_2(7): 2-18-704, 33-31-111, 33-35-306
SB0422_2(8): 2-18-704, 33-31-111, 33-35-306
SB0422_2(9): 2-18-704, 33-31-111, 33-35-306
SB0422_2: 2-18-704, 33-31-111, 33-35-306
SB0422_3(1): 2-18-704, 33-31-111, 33-35-306
SB0422_3(2): 2-18-704, 33-31-111, 33-35-306
SB0422_3(3): 2-18-704, 33-31-111, 33-35-306
SB0422_3(4): 2-18-704, 33-31-111, 33-35-306
SB0422_3(5): 2-18-704, 33-31-111, 33-35-306
SB0422_3(6): 2-18-704, 33-31-111, 33-35-306
SB0422_3: 2-18-704, 33-31-111, 33-35-306
SB0422_X(1): 2-18-704, 33-31-111, 33-35-306
SB0422_X(2): 2-18-704, 33-31-111, 33-35-306
SB0422_X(3): 2-18-704, 33-31-111, 33-35-306
SB0422_X(4): 2-18-704, 33-31-111, 33-35-306
SB0422_X(5): 2-18-704, 33-31-111, 33-35-306
SB0422_X(6): 2-18-704, 33-31-111, 33-35-306
SB0422_X(7): 2-18-704, 33-31-111, 33-35-306
SB0422_X(8): 2-18-704, 33-31-111, 33-35-306
SB0422_X(9): 2-18-704, 33-31-111, 33-35-306
SB0422_X: 2-18-704, 33-31-111, 33-35-306